Friday, December 20, 2013 3:55:29 PM
All those things are potentialities, but if Mesa can maintain the sales they claim for Oct. & Nov., then approaching $50M is not out of the range of possibilities. What that will that mean for the stock price, on a fully diluted basis is impossible to say, however I believe that they stated that these are high margin products, What's a high margin product?
According to the WHO, typical drug company profit margins are 30%.
http://www.who.int/trade/glossary/story073/en/
If they can do $50M at a 30% margin, that would be $15M in profits. Even at 1.1 billion shares outstanding, that's $0.0136 EPS. Whats the right P/E for a drug company? 5? 10?
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM